Inventor · disambiguated record
Piotr Zielenkiewicz
Also filed as: ZIELENKIEWICZ PIOTR
3 granted patents·5 pending applications·0 citations·filing 2011–2021
53Inventor score
Files withINST BIOCHEMII I BIOFIZYKI PAN4INST BIOCHEMII BIOFIZYKI PAN1INST BIOCHEMII I BIOFIZYKI POLSKIEJ AKADEMII NAUK1ODOLCZYK NORBERT1PASTEUR INSTITUT1
Top patents by PatentIndex Score
8 records- 0149US10420738B2Compounds as modulators of a mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunctionINST BIOCHEMII I BIOFIZYKI PAN·Filed 2015·Granted Sep 24, 2019·0 cites·3 claims
- 0247US10463639B2Compounds as modulators of a mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunctionINST BIOCHEMII I BIOFIZYKI PAN·Filed 2015·Granted Nov 5, 2019·0 cites·14 claims
- 0347US10398665B2Compounds as modulators of a mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunctionINST BIOCHEMII I BIOFIZYKI PAN·Filed 2015·Granted Sep 3, 2019·0 cites·8 claims
- 0444US2013303761A1Compounds as modulators of a mutant cftr protein and their use for treating diseases associated with cftr protein malfunctionODOLCZYK NORBERT·Filed 2011·Application pending·0 cites
- 0544US2024082341A1Peptide for use in the treatment or prevention of covid-19INST BIOCHEMII I BIOFIZYKI POLSKIEJ AKADEMII NAUK·Filed 2021·Application pending·0 cites
- 0642US2016000778A1Compounds as modulators of a mutant cftr protein and their use for treating diseases associated with cftr protein malfunctionINST BIOCHEMII BIOFIZYKI PAN·Filed 2015·Application pending·0 cites
- 0736US2019391160A1Methods and compositions for modifying cystic fibrosis transmembrane conductance regulator activityPASTEUR INSTITUT·Filed 2017·Application pending·0 cites
- 0831US2016272966A1Method of using a miR172 Molecule for Decreasing InflammationINST BIOCHEMII I BIOFIZYKI PAN·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Piotr Zielenkiewicz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →